Li Shenghao, Hao Liyuan, Hu Xiaoyu
Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Front Pharmacol. 2023 Aug 17;14:1242955. doi: 10.3389/fphar.2023.1242955. eCollection 2023.
Mitochondrial dysfunction plays an important role in the occurrence and development of different liver diseases. Oxidative phosphorylation (OXPHOS) dysfunction and production of reactive oxygen species are closely related to mitochondrial dysfunction, forcing glycolysis to become the main source of energy metabolism of liver cells. Moreover, glycolysis is also enhanced to varying degrees in different liver diseases, especially in liver cancer. Therefore, targeting the glycolytic signaling pathway provides a new strategy for the treatment of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis associated with liver cancer. Natural products regulate many steps of glycolysis, and targeting glycolysis with natural products is a promising cancer treatment. In this review, we have mainly illustrated the relationship between glycolysis and liver disease, natural products can work by targeting key enzymes in glycolysis and their associated proteins, so understanding how natural products regulate glycolysis can help clarify the therapeutic mechanisms these drugs use to inhibit liver disease.
线粒体功能障碍在不同肝脏疾病的发生和发展中起重要作用。氧化磷酸化(OXPHOS)功能障碍和活性氧的产生与线粒体功能障碍密切相关,迫使糖酵解成为肝细胞能量代谢的主要来源。此外,在不同的肝脏疾病中,尤其是肝癌,糖酵解也会不同程度地增强。因此,靶向糖酵解信号通路为治疗非酒精性脂肪性肝病(NAFLD)和与肝癌相关的肝纤维化提供了一种新策略。天然产物调节糖酵解的多个步骤,用天然产物靶向糖酵解是一种很有前景的癌症治疗方法。在这篇综述中,我们主要阐述了糖酵解与肝脏疾病之间的关系,天然产物可以通过靶向糖酵解中的关键酶及其相关蛋白发挥作用,因此了解天然产物如何调节糖酵解有助于阐明这些药物用于抑制肝脏疾病的治疗机制。